Dr Martin Forster, Consultant Medical Oncologist
Dr Martin Forster
Consultant Medical Oncologist
Dr Martin Forster MBBS, FRCP, PhD
Consultant Medical Oncologist
Dr Martin Forster
Consultant Medical Oncologist MBBS, FRCP, PhD
Areas of expertise
- Medical oncology
- Lung cancer
- Head and neck cancer
- Thoracic cancer
- Chemotherapy
Recommendations for Dr Forster
These recommendations are for information purposes only. Doctors providing recommendations do so in good faith and are not responsible for clinical outcomes.
Recommended by:
About Dr Martin Forster
GMC number: 4129392
Year qualified: 1994
Place of primary qualification: University of Newcastle upon Tyne
Dr Martin Smith is a distinguished consultant in medical oncology at University College Hospital (UCH) and a clinical senior lecturer at University College London (UCL). He specialises in the treatment and management of lung and head and neck cancers. Dr Smith graduated from the University of Newcastle upon Tyne and gained extensive general medical experience in New Zealand, Australia, and the United Kingdom. He became a member of the Royal College of Physicians (UK) in 2000.
Dr Smith has dedicated his career to cancer care, training in medical oncology at the Oxford Radcliffe and Royal Marsden NHS Trusts. He earned a PhD from the Institute for Cancer Research in London and was honoured with the EORTC-PAMM Young Investigator Award in 2004. Completing his specialist training in medical oncology in 2008, he was appointed as a UCL clinical senior lecturer and UCH consultant in medical oncology in 2009.
Since his appointment, Dr Smith has been at the forefront of cancer research, running a research-based practice and serving as principal or chief investigator for over 20 early and late-phase clinical trials. His research interests focus on drug development and leveraging the growing understanding of cancer biology to design studies that identify patient populations most likely to benefit from new drugs and drug combinations.
Dr Smith is deeply involved in the management of patients with lung and head and neck cancers. His expertise includes chemotherapy, drug development, and cancer biology. He is particularly interested in the biological mechanisms that lead to the development of these cancers, aiming to improve patient outcomes through innovative treatment strategies.
Dr Smith's commitment to advancing cancer treatment and his extensive experience in clinical trials make him a leading figure in the field of medical oncology.
Areas of expertise
- Thoracic oncology
- Head oncology
- Neck oncology
Professional memberships
Articles by Dr Martin Forster
Study protocol for the saron trial: a multicentre, randomised controlled phase trial comparing the addition of stereotactic ablative radiotherapy and radical radiotherapy with standard chemotherapy alone for oligometastatic non-small cell lung cancer
Fc-optimized anti-cd25 depletes tumor-infiltrating regulatory t cells and synergizes with pd-1 blockade to eradicate established tumors
Antitumor activity of lurbinectedin (pm01183) and doxorubicin in relapsed small-cell lung cancer: results from a phase i study
Phase 1/2a trial of intravenous bal101553, a novel controller of the spindle assembly checkpoint, in advanced solid tumours
Guidance by molecular selection improves the outcome of early phase treatment for gynecological (gyn) cancers